This metabolite provides a PDE selectivity profile much like sildenafil and an in vitro potency for PDE5 about 50% on the father or mother drug. Plasma concentrations of the metabolite are approximately 40% of those viewed for sildenafil, so the metabolite accounts for approximately twenty% of silde